Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Watson Pharmaceuticals |
---|---|
Information provided by: | Watson Pharmaceuticals |
ClinicalTrials.gov Identifier: | NCT00354692 |
This pilot study will compare the effects of sodium ferric gluconate complex and iron sucrose on urine concentrations of various chemicals including protein
Condition | Intervention | Phase |
---|---|---|
Kidney Failure, Chronic Anemia, Iron-Deficiency |
Drug: Sodium Ferric Gluconate and Iron sucrose |
Phase IV |
Study Type: | Interventional |
Study Design: | Randomized, Open Label, Active Control, Crossover Assignment |
Official Title: | A Randomized Cross-Over Pilot Study of the Effect of Sodium Ferric Gluconate Complex vs. Iron Sucrose on Proteinuria in Non-Dialysis Chronic Kidney Disease Patients |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
United States, California | |
Glendale, California, United States | |
United States, Louisiana | |
Shreveport, Louisiana, United States |
Study Director: | Adel R. Rizkala, Pharm.D., MS | Watson Laboratories, Inc. |
Study ID Numbers: | FER0601 |
Study First Received: | July 18, 2006 |
Last Updated: | September 10, 2007 |
ClinicalTrials.gov Identifier: | NCT00354692 |
Health Authority: | United States: Food and Drug Administration |
Renal Insufficiency Metabolic Diseases Hematologic Diseases Kidney Failure, Chronic Anemia Iron Metabolism Disorders Anemia, Iron-Deficiency Ferric oxide, saccharated |
Proteinuria Urologic Diseases Renal Insufficiency, Chronic Ferric gluconate Kidney Diseases Metabolic disorder Iron Kidney Failure |
Hematinics Therapeutic Uses Hematologic Agents Anemia, Hypochromic Pharmacologic Actions |